Please login to the form below

Not currently logged in


This page shows the latest Theranos news and features for those working in and with pharma, biotech and healthcare.

Latest news

  • Daily Brief: AI to boost early NHS cancer diagnosis, AZ shareholder revolt, Juluca approval Daily Brief: AI to boost early NHS cancer diagnosis, AZ shareholder revolt, Juluca approval

    DIGITAL HEALTH. The inside story of Theranos’ health tech fraud. Published today is the book by Wall Street Journal reporter John Carreyou, Bad Blood: Secrets and Lies in a Silicon Valley ... Startup.  It tells the story of Theranos and its founder

  • Theranos and its CEO settle 'massive fraud' charges Theranos and its CEO settle 'massive fraud' charges

    During this time Silicon Valley-based Theranos, which wanted to revolutionise blood testing, raised more than $700 million from investors. ... Investors were also falsely told by Theranos that the US army used its blood analyser on the battlefield in

  • 2018 by Darwin 2018 by Darwin

    That’s what we learned from Theranos. Darwin, Dawkins and many of my other scientific heroes have been circumspect about the predictive power of evolutionary theory, and rightly so.

  • Acting at random Acting at random

    Looking from the outside, this seems to be Elizabeth Holme's problem at Theranos. ... Great technological and commercial capabilities but something went wrong in the part of Theranos's routineome that expresses the genes for regulatory capabilities.

More from news
Approximately 2 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

My MS journey: one patient's search for innovation
David Lazarus charts his journey from initial MS diagnosis in 1990 to his experience participating in innovative clinical trials, along with his advice for other patients....
Biotech profile: Tom Evans, CEO, Vaccitech.
Can UK company be first to develop a universal flu vaccine?...
The social dilemma: is it time for pharma to join the party?
Chris Ross explores why social media still isn’t trending for pharma, and how it can join in the fun...